Broadleaf Partners’s AbbVie ABBV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$894K	Sell	4,818 -945	-16%	-$175K	0.2%	50
2025 Q1	$1.21M	Sell	5,763 -1,800	-24%	-$377K	0.32%	47
2024 Q4	$1.34M	Sell	7,563 -335	-4%	-$59.5K	0.31%	43
2024 Q3	$1.56M	Hold	7,898	–	–	0.37%	43
2024 Q2	$1.35M	Sell	7,898 -10	-0.1%	-$1.72K	0.33%	40
2024 Q1	$1.44M	Buy	7,908 +10	+0.1%	+$1.82K	0.37%	44
2023 Q4	$1.22M	Hold	7,898	–	–	0.36%	45
2023 Q3	$1.18M	Sell	7,898 -33	-0.4%	-$4.92K	0.39%	39
2023 Q2	$1.07M	Buy	7,931 +2,500	+46%	+$337K	0.35%	42
2023 Q1	$866K	Hold	5,431	–	–	0.31%	43
2022 Q4	$878K	Hold	5,431	–	–	0.35%	42
2022 Q3	$729K	Hold	5,431	–	–	0.3%	42
2022 Q2	$832K	Hold	5,431	–	–	0.35%	40
2022 Q1	$880K	Hold	5,431	–	–	0.29%	42
2021 Q4	$735K	Hold	5,431	–	–	0.23%	45
2021 Q3	$586K	Hold	5,431	–	–	0.19%	48
2021 Q2	$612K	Hold	5,431	–	–	0.21%	49
2021 Q1	$588K	Hold	5,431	–	–	0.22%	49
2020 Q4	$582K	Buy	5,431 +150	+3%	+$16.1K	0.23%	45
2020 Q3	$463K	Hold	5,281	–	–	0.2%	48
2020 Q2	$518K	Hold	5,281	–	–	0.25%	44
2020 Q1	$402K	Hold	5,281	–	–	0.26%	44
2019 Q4	$468K	Hold	5,281	–	–	0.26%	43
2019 Q3	$400K	Sell	5,281 -1,050	-17%	-$79.5K	0.25%	45
2019 Q2	$460K	Hold	6,331	–	–	0.29%	41
2019 Q1	$510K	Hold	6,331	–	–	0.36%	40
2018 Q4	$584K	Sell	6,331 -45,103	-88%	-$4.16M	0.47%	40
2018 Q3	$4.87M	Sell	51,434 -629	-1%	-$59.5K	3.26%	8
2018 Q2	$4.82M	Buy	52,063 +12,039	+30%	+$1.12M	3.53%	7
2018 Q1	$3.79M	Buy	40,024 +5,107	+15%	+$483K	2.91%	13
2017 Q4	$3.38M	Buy	+34,917	New	+$3.38M	2.8%	11